Glybera is a drug capable of curing a rare genetic disease caused by a deficiency of lipoprotein lipase (LPLD) that affects the pancreas. The drug alters the individual's genetic load and completely cures the disease and was created by the UniQure laboratory.
Glybera indications
Treatment of lipoprotein lipase deficiency.
Glybera Price
The price of Glybera is approximately 3 million reais and it should start to be marketed from 2013 in Europe.
Side effects of Glybera
Glyebera is well tolerated and does not cause any unpleasant side effects.
How to use Glybera
Unique series of small injections in the leg, given by doctors properly trained in centers of excellence, with experience in the treatment of this disease to ensure the safety of this new treatment.
